positive living with MS
Please select your professional status below if you are a medical professional or click here to return to the msactivesource.co.uk website if you are not.
Clicking on the relevant title certifies that you are a healthcare professional accessing in your capacity as a healthcare professional.
MS Nurse...click here
Nurse...click here
Doctor...click here
MS Specialist...click here
You are leaving www.msactivesource.co.uk, a web site of Biogen Idec UK & Ireland. Links to all outside web sites are provided as a resource to our visitors. Biogen Idec accepts no responsibility for the content of other web sites.
Diagnosis of MS is based on medical history, symptoms and confirmed by further tests:
If an individual has suffered two separate episodes of symptoms characteristic of MS and has consistent abnormalities on physical examination, MS can usually be diagnosed without the need for further neurological tests. However, if an individual has had only one episode of symptoms, neurological tests can be used to help confirm a diagnosis of MS at an earlier stage of disease.
Magnetic resonance imaging (MRI) of the brain and spine is widely used to confirm a diagnosis of MS. This technique uses strong magnetic fields to produce an image which can reveal damage to the white matter of the brain, characteristic of MS. (figure 5) Demyelination can be detected even when the damage is not sufficient to cause clinical symptoms.
Figure 5. MRI scan of the brain with typical MS lesions. Round-to-oval-shaped MS
lesions can be seen (circled in red) around the butterfly shape (dark)
Evoked potential tests measure the speed with which messages are transmitted from specific parts of the body (such as the eyes, ears or skin) to the brain. If demyelination has occurred, transmission of the electrical signals along the neurones is slowed down and this can be detected by evoked potential tests.
A third test used to confirm a diagnosis of MS is to determine whether antibodies are present in the cerebrospinal fluid (CSF), the fluid which surrounds the brain. Antibodies are present in 85–9 5% of patients with MS (although they can also be detected in patients with other disease). In order to carry out this test a lumbar puncture is performed under local anaesthetic. A needle is inserted into the lower back to collect a sample of CSF to test for antibodies.
Multiple Sclerosis is a disease of unknown origin that affects the central nervous system.
Supported by
This website is intended for use in Great Britain and Northern Ireland.
Please click here for msactivesource.ie
Page last updated: 22 Jun 2010
|
| This site complies to the HONcode standard for trustworthy health information: verify here. |